# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-010730
Filing Date
2025-04-02
Accepted
2025-04-02 17:17:25
Documents
117
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | nby20241231_10k.htm iXBRL | 10-K | 3039348
2 | EXHIBIT 4.1 | ex_793560.htm | EX-4.1 | 16616
3 | EXHIBIT 19 | ex_792676.htm | EX-19 | 93951
4 | EXHIBIT 21 | ex_794259.htm | EX-21 | 1464
5 | EXHIBIT 23.1 | ex_796545.htm | EX-23.1 | 3409
6 | EXHIBIT 31.1 | ex_794260.htm | EX-31.1 | 8499
7 | EXHIBIT 31.2 | ex_794261.htm | EX-31.2 | 8491
8 | EXHIBIT 32.1 | ex_794262.htm | EX-32.1 | 4677
9 | EXHIBIT 32.2 | ex_794263.htm | EX-32.2 | 4313
15 |  | novalogosm.jpg | GRAPHIC | 14118
| Complete submission text file | 0001437749-25-010730.txt |  | 15673283

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20241231.xsd | EX-101.SCH | 134340
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20241231_def.xml | EX-101.DEF | 896970
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20241231_lab.xml | EX-101.LAB | 681638
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20241231_pre.xml | EX-101.PRE | 941412
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nby-20241231_cal.xml | EX-101.CAL | 70241
120 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20241231_10k_htm.xml | XML | 3132773

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 25806084
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)